ARQT Arcutis Biotherapeutics, Inc. Company Cash Funds

Symbol and logo of brand Arcutis Biotherapeutics, Inc. (ARQT)

The cash position of Arcutis Biotherapeutics (ARQT) demonstrates financial resilience, with 0.26 serving as the current value of this metric. Liquidity supports the Zoryve delivery ecosystem, which strengthens patient brand loyalty. Growth is based on the market launch of safe, non-hormonal dermatitis treatments. High physician confidence and consumer loyalty are driving the company's rapid reputational growth within the dermatology sector.

Arcutis - ARQT Company Cash Balance (period 07/04/2022 - 11/21/2026)

Analytical breakdowns and data insights for company Arcutis (ARQT)

- stock quotes and analyst forecast:
Analysis of all company metrics:Arcutis Biotherapeutics Inc ARQT
Brand item of Arcutis Biotherapeutics, Inc.

The development of specialized logistics chains by Arcutis Biotherapeutics (ARQT) for the distribution of dermatological products requires a significant liquidity reserve to maintain supply margins. Analyzing this cash flow chart, an investor assesses the volume of available funds, which determines the company's ability to finance operating activities and guarantees the stability of free cash flow without the need to attract expensive external capital.